Trials / Terminated
TerminatedNCT00292747
Drotaverine in Dysmenorrhoea Treatment
Comparison of the Efficacy and Tolerability of Drotaverine 80 mg, Ibuprofen 400 mg and Their Combination in a Calendar Packaging for the Treatment of Primary and Secondary Dysmenorrhoea
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 480 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to show that the combination of drotaverine 80mg and ibuprofen 400 mg is more effective and as well-tolerated as ibuprofen 400 mg or drotaverine 80 mg administered alone, in the treatment of primary and secondary dysmenorrhoea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drotaverine | |
| DRUG | Drotaverine Placebo | |
| DRUG | Ibuprofen | |
| DRUG | Ibuprofen Placebo |
Timeline
- Start date
- 2005-05-25
- Primary completion
- 2006-02-28
- Completion
- 2006-02-28
- First posted
- 2006-02-16
- Last updated
- 2017-08-08
Locations
1 site across 1 country: Hungary
Source: ClinicalTrials.gov record NCT00292747. Inclusion in this directory is not an endorsement.